Metraipolis › archive › dc_08c51760e71d

Cost-effectiveness of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for high-risk locally advanced cervical cancer in Saudi… — Europe PMC PMID:42826320

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42826320
DOI
10.1097/md.0000000000050990
License (as archived)
solo-consultazione
Archived
2026-10-07T17:04:16.966Z
SHA-256 of the archived text
2f982875ad16475ad4b652f0e313ee9598194f7bb0499d7b36f968da1bedc3bc
Stable URL of this page
https://metraipolis.com/documento/dc_08c51760e71d

How to cite

Cost-effectiveness of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for high-risk locally advanced cervical cancer in Saudi… — Europe PMC PMID:42826320 — Europe PMC (en), https://europepmc.org/article/MED/42826320 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08c51760e71d (Metraipolis archive dc_08c51760e71d, sha256 2f982875ad16475ad4b652f0e313ee9598194f7bb0499d7b36f968da1bedc3bc)
BibTeX
@misc{dc08c51760e71d,
  title = {Cost-effectiveness of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for high-risk locally advanced cervical cancer in Saudi… — Europe PMC PMID:42826320},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42826320},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08c51760e71d; sha256 2f982875ad16475ad4b652f0e313ee9598194f7bb0499d7b36f968da1bedc3bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42826320. Agents can read the archived copy with the MCP tool read_document.